Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 12/19/2025 | PUT | $22.50 | 86,637 | +35,313 | +68.80% |
| 12/19/2025 | CALL | $27.00 | 33,764 | +6,533 | +23.99% |
| 12/19/2025 | CALL | $26.50 | 24,054 | +5,086 | +26.81% |
| 01/16/2026 | PUT | $26.00 | 14,141 | +4,743 | +50.47% |
| 02/20/2026 | CALL | $30.00 | 7,422 | +3,998 | +116.76% |
| 12/19/2025 | CALL | $28.00 | 7,741 | +2,719 | +54.14% |
| 01/16/2026 | PUT | $24.00 | 21,348 | -346 | -1.59% |
| 06/18/2026 | CALL | $30.00 | 30,306 | -814 | -2.62% |
| 12/19/2025 | PUT | $25.00 | 72,538 | -823 | -1.12% |
| 12/19/2025 | CALL | $26.00 | 85,054 | -1,021 | -1.19% |
| 01/16/2026 | PUT | $25.00 | 60,631 | -1,220 | -1.97% |
| 12/19/2025 | CALL | $29.00 | 30,558 | -5,683 | -15.68% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.02% | 170.64M | 6.14B |
| Vanguard 500 Index Fund | 2.30% | 129.76M | 4.67B |
| Washington Mutual Investors Fund | 1.42% | 80.41M | 2.89B |
| Fidelity 500 Index Fund | 1.09% | 61.54M | 2.21B |
| SPDR S&P 500 ETF Trust | 1.08% | 60.77M | 2.19B |
| American Balanced Fund | 1.00% | 56.61M | 2.04B |
| Income Fund of America Inc | 0.93% | 52.68M | 1.9B |
| iShares Core S&P 500 ETF | 0.89% | 50.1M | 1.8B |
| Vanguard Index-Value Index Fund | 0.86% | 48.51M | 1.75B |
| Vanguard Specialized-Health Care Fund | 0.86% | 48.32M | 1.74B |
S&P 500 Stays Range-Bound as NFP Cools Without Forcing Panic Fed Cuts
12/16 03:16 pm
Investing.com
Read more1 Bold Prediction for Viking Therapeutics in 2026
12/16 02:15 pm
The Motley Fool
Read morePfizer Sees Slower 2026 Growth Despite Pipeline Push, Cost Cuts
12/16 10:28 am
Benzinga
Read morePfizer: Can $108B Bet on Obesity Drugs Revive Its Struggling Stock?
12/16 08:30 am
Investing.com
Read moreWhere Will Eli Lilly Be in 10 Years?
12/16 06:15 am
The Motley Fool
Read morePfizer Faces Another Quiet Year As Patent Losses Cloud 2026 Outlook: Analyst
12/15 01:31 pm
Benzinga
Read moreWill Dogecoin Reach $1 By the End of the Year?
12/15 07:15 am
The Motley Fool
Read moreShould You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead?
12/14 04:27 pm
The Motley Fool
Read moreWomen’s Healthcare Market Worth USD 46.76 Billion by 2033 Driven by Rising Demand for Reproductive, Preventive, and Digital Health Solutions – SNS Insider
12/13 09:10 pm
GlobeNewswire Inc.
Read moreAlameda Health System wins equity award for breast cancer screening campaign
12/10 04:39 pm
GlobeNewswire Inc.
Read morePfizer's Tukysa Combo Shows Strong PFS Benefit In Metastatic Breast Cancer
12/10 02:20 pm
Benzinga
Read moreDown 50%, Should You Buy the Dip on Pfizer?
12/09 05:15 pm
The Motley Fool
Read moreArcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri
12/08 05:00 pm
GlobeNewswire Inc.
Read moreAutism Spectrum Disorder Market to Reach USD 4.07 Billion by 2033, Driven by Rising Awareness, Early Diagnosis & Advances in Personalized Therapeutics | SNS Insider
12/07 09:43 am
GlobeNewswire Inc.
Read moreOphthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - SNS Insider
12/07 09:05 am
GlobeNewswire Inc.
Read moreNurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition
12/06 10:30 am
GlobeNewswire Inc.
Read morePeptide Therapeutics Market Size to Reach USD 82.19 Billion by 2032; Surging Requirements for Targeted Medicines in Oncology Augment Market Expansion - SNS Insider
12/06 10:10 am
GlobeNewswire Inc.
Read moreDo These 3 Healthcare Stocks Need a Checkup?
12/05 05:05 pm
The Motley Fool
Read moreIs This Pharmaceutical Giant a Buy After a Major Acquisition?
12/05 01:05 pm
The Motley Fool
Read moreWhat Trends Are Defining the Hemophilia Inhibitors Market Growth?
12/04 10:00 am
GlobeNewswire Inc.
Read moreSickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight
12/03 02:00 pm
GlobeNewswire Inc.
Read moreSeasonal Vaccines Market Accelerating Growth and Rising Opportunities Through 2035
12/03 11:00 am
GlobeNewswire Inc.
Read moreVaccine Development Company Landscape Report 2025: Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis
12/02 05:37 am
GlobeNewswire Inc.
Read moreNurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg (NX-5948) To Be Presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition
12/01 08:00 am
GlobeNewswire Inc.
Read more2 Undervalued, High-Quality Companies to Buy Now and Hold Forever
11/30 10:05 pm
The Motley Fool
Read moreThis 7% Yielder Could Be a Top AI Play
11/30 05:04 pm
The Motley Fool
Read moreAtopic Dermatitis Drugs Market to Reach $29.43 Billion by 2032, Driven by Rising Disease Prevalence & Strong Therapeutic Innovation | SNS Insider
11/28 01:28 am
GlobeNewswire Inc.
Read moreGeriatric Care Services Market is expected to generate a revenue of USD 2.03 Billion by 2032, Globally, at 7.98% CAGR: Verified Market Research®
11/27 11:50 pm
GlobeNewswire Inc.
Read moreHuman Growth Hormone Injection Market Size Expected to Reach USD 8.54 Bn by 2035
11/27 11:00 am
GlobeNewswire Inc.
Read moreAnti-Obesity Drugs Market Size to Reach $35.52 Billion by 2032, Driven by Advancements in Weight Management Therapies and Rising Obesity Prevalence | SNS Insider
11/27 08:54 am
GlobeNewswire Inc.
Read moreHave $2,000 to Invest? Here Are 4 of My Favorite Dividend Stocks for the Next 5 Years
11/27 05:01 am
The Motley Fool
Read moreDid Pfizer Just Say "Checkmate" to Novo Nordisk?
11/26 05:15 am
The Motley Fool
Read moreIs This the Best Value Stock to Buy While Markets Are Volatile?
11/25 07:24 am
The Motley Fool
Read moreWant Over $7,000 in Annual Dividends? Invest $25,000 in Each of These 4 Stocks.
11/25 06:30 am
The Motley Fool
Read moreArvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)
11/24 08:00 am
GlobeNewswire Inc.
Read more2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon
11/22 10:20 am
The Motley Fool
Read morePfizer's New mRNA Flu Vaccine Outperforms Traditional Shot Against Predominant Strains
11/21 11:48 am
Benzinga
Read moreIs Pfizer's 6.9%-Yielding Dividend Still Safe?
11/20 10:30 am
The Motley Fool
Read morePolycystic Ovary Syndrome Treatment Market Expected to Reach USD 9.12 Bn by 2034
11/19 12:00 pm
GlobeNewswire Inc.
Read moreHospital Care Collaboration and Licensing Agreements Analysis Report and Directory 2025: Upfront, Milestone, and Royalties for 726 Deals by Company A-Z, Therapy Focus and Technology Type
11/19 11:59 am
GlobeNewswire Inc.
Read moreMetabolic Collaboration and Licensing Agreements Analysis Report and Directory 2025: Upfront, Milestone, and Royalties for 576 Deals by Company A-Z, Therapy Focus and Technology Type
11/19 11:58 am
GlobeNewswire Inc.
Read moreCan AI Drive Peloton's Comeback?
11/18 03:23 pm
The Motley Fool
Read moreNovo Nordisk's New Chair Aims To Reinforce Board As Foundation Tightens Control
11/17 11:11 am
Benzinga
Read moreThis Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?
11/17 06:25 am
The Motley Fool
Read moreDown 55%, Should You Buy the Dip on Pfizer?
11/17 05:35 am
The Motley Fool
Read morePfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run
11/13 12:10 pm
Benzinga
Read moreSanta Claus Rally: 3 Discounted Stocks Heading Into 2026
11/12 01:35 pm
Investing.com
Read moreNovo Nordisk's $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker
11/12 10:24 am
Benzinga
Read more